摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2-Hydroxyethoxymethyl)-5-[1-(pyren-1-ylmethyl)triazol-4-yl]-1,2,4-triazole-3-carboxamide | 1193363-71-1

中文名称
——
中文别名
——
英文名称
1-(2-Hydroxyethoxymethyl)-5-[1-(pyren-1-ylmethyl)triazol-4-yl]-1,2,4-triazole-3-carboxamide
英文别名
——
1-(2-Hydroxyethoxymethyl)-5-[1-(pyren-1-ylmethyl)triazol-4-yl]-1,2,4-triazole-3-carboxamide化学式
CAS
1193363-71-1
化学式
C25H21N7O3
mdl
——
分子量
467.487
InChiKey
RKEHQYQGYGWWEA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    35
  • 可旋转键数:
    8
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.16
  • 拓扑面积:
    134
  • 氢给体数:
    2
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • NOVEL TRIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
    申请人:Inserm Transfert
    公开号:EP2279193A1
    公开(公告)日:2011-02-02
  • US8563526B2
    申请人:——
    公开号:US8563526B2
    公开(公告)日:2013-10-22
  • [EN] NOVEL TRIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS<br/>[FR] NOUVEAUX DÉRIVÉS DE TRIAZOLE, LEUR PRÉPARATION ET LEUR APPLICATION EN THÉRAPEUTIQUE
    申请人:INSERM TRANSFERT
    公开号:WO2009133147A1
    公开(公告)日:2009-11-05
    The present invention relates to novel compounds of formula (A): in the form of a free base or of an addition salt with an acid. The invention also relates to process of preparation of compounds of formula (A), to composition comprising them and to their application in therapeutics and in particular in cancers.
  • A Novel Bitriazolyl Acyclonucleoside Endowed with Dual Antiproliferative and Immunomodulatory Activity
    作者:Yi Xia、Menghua Wang、Olivier Demaria、Jingjie Tang、Palma Rocchi、Fanqi Qu、Juan L. Iovanna、Lena Alexopoulou、Ling Peng
    DOI:10.1021/jm300534u
    日期:2012.6.14
    A novel bitriazolyl acyclonudeoside was discovered to exhibit powerful antiproliferative effects on different cancer cell lines through caspase-dependent apoptosis and at the same time stimulate the immune response in dendritic cells via Toll-like receptor 7 (TLR7) signaling. This promising compound with dual anticancer and immunomodulatory activity may represent a new generation of highly efficacious drug candidates for use in cancer therapy.
查看更多